MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Long term outcome of STN-DBS for Parkinson Disease patients using Directional mode setting programs

K. Kimura, H. Kishida, T. Kawasaki, N. Ueda, F. Tanaka (Yokohama, Japan)

Meeting: 2019 International Congress

Abstract Number: 2045

Keywords: Deep brain stimulation (DBS), Parkinsonism, Subthalamic nucleus(SIN)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Surgical Therapy

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To survey the long term effectiveness of the directional mode setting programs for Parkinson Disease patients with Subthalamic Deep Brain Stimulation (STN-DBS).

Background: Background: STN-DBS is a symptomatic established treatment for advanced Parkinson Disease (PD). Appropriate programming is essential for maximizing the effect of the therapy. Inappropriate setting results stimulation evoked complications such as capsular response or psychiatric problems. Directional lead is developed for fine stimulation controls. We evaluated long term outcome of STN-DBS using directional mode settings.

Method: Methods: We include forty-eight PD patients receiving STN-DBS in this study. These forty-eight patients received bilateral STN-DBS using Boston Scientific Vercise series IPGs and Boston Scientific Twist eight contacts DBS leads or Cartesia Directional leads. These patients were divided into two groups. Directional mode (DL) settings group includes patients implanted with directional leads and receiving DL setting programs. Patients implanted with conventional leads, or directional leads receiving ring mode setting programs were included to conventional (CV) setting group. We evaluated and compared long-term outcome of motor symptoms and DBS program at twelve and twenty-six weeks after implantation between DL setting group and CV setting group.

Results: Results: twenty-eight patients received DBS with directional lead, and eighteen of them received DL settings. There was no significant difference in UPDRS-III reduction rate (58.1% in DL and 58.9% in CV). The current value of the DL setting was lower than conventional mode settings (4.10±0.55mA in DL and 6.58±2.70mA in CV (p<0.05)).

Conclusion: Conclusions: although we could not detect the difference for motor improvement between the devices, the lower current was needed for DL settings compared to conventional settings. That meant directional mode DBS needed lower current for motor control. DL stimulation is hard to evoke complications, because lower stimulation is difficult to evoke complications. As the disease progresses, it is sometimes necessary to strengthen the current values, so the DL settings leaves room for future adjustment.

To cite this abstract in AMA style:

K. Kimura, H. Kishida, T. Kawasaki, N. Ueda, F. Tanaka. Long term outcome of STN-DBS for Parkinson Disease patients using Directional mode setting programs [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/long-term-outcome-of-stn-dbs-for-parkinson-disease-patients-using-directional-mode-setting-programs/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/long-term-outcome-of-stn-dbs-for-parkinson-disease-patients-using-directional-mode-setting-programs/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley